SEC Form D · filed February 26, 2020
Immunomic Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Ronald P. Thiboutot · ROCKVILLE, MDDirectorJames W. Wishart · ROCKVILLE, MDDirectorMichael D. Lack · ROCKVILLE, MDDirectorC. E. Winzer · ROCKVILLE, MDExec · DirectorWilliam G. Hearl · ROCKVILLE, MDExec · DirectorNancy Lewis · New York, NYExec · DirectorPatrick Puzzuoli · New York, NYDirectorJacob Silverman · New York, NYDirectorNoah Gottdiener · New York, NYDirectorEdward W. Forman · New York, NYExec · DirectorHanieh Sadathendi · Los Angeles, CAExec · DirectorLeise N. Rosman · Phoenix, AZDirectorKris N. Krane · Phoenix, AZExec · DirectorKarl N. Chowscano · Phoenix, AZDirectorEric A. Naison-Phillips · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗